264
Views
6
CrossRef citations to date
0
Altmetric
Clincial

Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis

, ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 388-394 | Received 14 Sep 2020, Accepted 31 Jan 2021, Published online: 01 Apr 2021

References

  • Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
  • Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology 1998;50:768–72.
  • Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, et al. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:519–27.
  • van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Airlie House ALS Clinical Trials Guidelines Group, et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019;92:e1610–e1623.
  • Taga A, Maragakis NJ. Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Rev Neurother. 2018;18:871–86.
  • Sugimoto K, Hiwasa T, Shibuya K, Hirano S, Beppu M, Isose S, et al. Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis. J Neuroimmunol. 2018;325:54–60.
  • Bunnell TM, Burbach BJ, Shimizu Y, Ervasti JM. β-Actin specifically controls cell growth, migration, and the G-actin pool . Mol Biol Cell. 2011;22:4047–58.
  • Moradi M, Sivadasan R, Saal L, Luningschror P, Dombert B, Rathod RJ, et al. Differential roles of α-, β-, and γ-actin in axon growth and collateral branch formation in motoneurons. J Cell Biol. 2017;216:793–814.
  • Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591–601.
  • Balendra R, Jones A, Jivraj N, Knights C, Ellis CM, Burman R, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:279–84.
  • Balendra R, Al KA, Fang T, Al-Chalabi AA. standard operating procedure for King's ALS clinical staging. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:159–64.
  • Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
  • Muto M, Mori M, Hiwasa T, Takiguchi M, Iwadate Y, Uzawa A, et al. Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J Neuroimmunol. 2015;284:30–6.
  • Yoshida Y, Hiwasa T, Machida T, Kobayashi E, Mine S, Matsushima J, et al. Elevation of Autoantibody in Patients with Ischemic Stroke. Neurol Med Chir (Tokyo). 2018;58:303–10.
  • Li G, Chang M, Jiang H, Xie H, Dong Z, Hu L. Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells. Cell Biochem Funct. 2011;29:30–5.
  • Alfadda AA, Benabdelkamel H, Masood A, Moustafa A, Sallam R, Bassas A, et al. Proteomic analysis of mature adipocytes from obese patients in relation to aging. Exp Gerontol. 2013;48:1196–203.
  • Zhou F, Chen X, Chen G, Yan J, Xiao Y. Identification of SAA and ACTB as potential biomarker of patients with severe HFMD using iTRAQ quantitative proteomics. Clin Biochem.2019;67:1–6.
  • Collins MA, An J, Hood BL, Conrads TP, Bowser RP. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. J Proteome Res. 2015;14:4486–501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.